| Table 3.2 Clients in treatment by type of care received and clients receiving methadone or buprenorphine: 2003-20071 Number and percent distribution |
||||||||||
| Type of care received and clients receiving methadone | Number of clients | Percent distribution | ||||||||
| 2003 | 2004 | 2005 | 2006 | 2007 | 2003 | 2004 | 2005 | 2006 | 2007 | |
| Total | 1,092,546 | 1,072,251 | 1,081,049 | 1,130,881 | 1,135,425 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Type of care received | ||||||||||
| Outpatient | 968,719 | 954,551 | 961,805 | 1,008,915 | 1,016,913 | 88.7 | 89.0 | 89.0 | 89.2 | 89.6 |
| Regular | 587,975 | 564,300 | 569,272 | 589,542 | 595,459 | 53.8 | 52.6 | 52.7 | 52.1 | 52.4 |
| Intensive | 128,127 | 121,862 | 125,573 | 128,706 | 132,977 | 11.7 | 11.4 | 11.6 | 11.4 | 11.7 |
| Detoxification | 11,770 | 12,064 | 13,474 | 12,579 | 12,705 | 1.1 | 1.1 | 1.2 | 1.1 | 1.1 |
| Day treatment/partial hospitalization | 27,728 | 28,133 | 24,928 | 24,039 | 22,297 | 2.5 | 2.6 | 2.3 | 2.1 | 2.0 |
| Methadone/buprenorphine maintenance | 213,119 | 228,192 | 228,558 | 254,049 | 253,475 | 19.5 | 21.3 | 21.1 | 22.5 | 22.3 |
| Residential (non-hospital) | 108,592 | 101,713 | 104,015 | 107,790 | 103,709 | 9.9 | 9.5 | 9.6 | 9.5 | 9.1 |
| Detoxification | 9,061 | 7,021 | 7,306 | 6,487 | 7,536 | 0.8 | 0.7 | 0.7 | 0.6 | 0.7 |
| Short-term treatment (30 days or fewer) | 22,926 | 21,758 | 23,360 | 22,234 | 24,171 | 2.1 | 2.0 | 2.2 | 2.0 | 2.1 |
| Long-term treatment (more than 30 days) | 76,605 | 72,934 | 73,349 | 79,069 | 72,002 | 7.0 | 6.8 | 6.8 | 7.0 | 6.3 |
| Hospital inpatient | 15,235 | 15,987 | 15,229 | 14,176 | 14,803 | 1.4 | 1.5 | 1.4 | 1.3 | 1.3 |
| Detoxification | 7,067 | 6,214 | 6,381 | 5,220 | 6,319 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 |
| Treatment | 8,168 | 9,773 | 8,848 | 8,956 | 8,484 | 0.7 | 0.9 | 0.8 | 0.8 | 0.7 |
| Clients receiving methadone or buprenorphine | ||||||||||
| Total | 227,003 | 243,358 | 240,935 | 265,786 | 265,716 | 20.8 | 22.7 | 22.3 | 23.5 | 23.4 |
| Clients receiving methadone | 227,003 | 240,961 | 235,836 | 258,752 | 262,684 | 20.8 | 22.5 | 21.8 | 22.9 | 23.1 |
| Clients receiving buprenorphine | - - | 2,397 | 5,099 | 7,034 | 3,032 | - - | 0.2 | 0.5 | 0.6 | 0.3 |
| 1 Survey reference dates were: March 31, 2003-2006, and March 30, 2007. See Appendix A for changes in the survey base, methods, and instruments that affect analysis of trends over time. | ||||||||||
| SOURCE: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS), 2003-2007. | ||||||||||